Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Meagher

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|November 11, 2025
Efficacy and safety of REGN9933<sup>A2</sup> and REGN7508<sup>Cat</sup> for preventing postoperative venous thromboembolism (ROXI-VTE-I and ROXI-VTE-II): two randomised, open-label, phase 2 trialsJeffrey I Weitz, Aaron P Kithcart, Meagan P O'Brien, et al.
Lancet (London, England)|January 26, 2024
Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 studyAhmet Ozen, Voranush Chongsrisawat, Asena Pinar Sefer, et al.
Lancet (London, England)|November 6, 2012
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 studyMarina Cuchel, Emma A Meagher, Hendrik du Toit Theron, et al.
The Australian and New Zealand Journal of Surgery|August 12, 1999
Practice parameters for the management of colonic cancer II: other issues. Recommendations of the Colorectal Surgical Society of AustraliaW Adams, J Cartmill, P Chapuis, et al.
The Australian and New Zealand Journal of Surgery|July 7, 1999
Practice parameters for the management of colonic cancer I: surgical issues. Recommendations of the Colorectal Surgical Society of AustraliaJ Moore, P Hewett, J C Penfold, et al.
Atherosclerosis|April 22, 2015
The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trialC Stefanutti, D J Blom, M R Averna, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|September 8, 2021
Mentoring Underrepresented Minority Physician-Scientists to SuccessAdina Kalet, Anne M Libby, Reshma Jagsi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2019
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding propertiesLynn E Macdonald, Karoline A Meagher, Matthew C Franklin, et al.
Lancet (London, England)|April 24, 2026
Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trialTuan Vu, Ali A Habib, Saiju Jacob, et al.
Science Immunology|December 17, 2021
Humanization of T cell-mediated immunity in miceMichael J Moore, Maggie Zhong, Johanna Hansen, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|November 11, 2025
Efficacy and safety of REGN9933<sup>A2</sup> and REGN7508<sup>Cat</sup> for preventing postoperative venous thromboembolism (ROXI-VTE-I and ROXI-VTE-II): two randomised, open-label, phase 2 trialsJeffrey I Weitz, Aaron P Kithcart, Meagan P O'Brien, et al.
Lancet (London, England)|January 26, 2024
Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 studyAhmet Ozen, Voranush Chongsrisawat, Asena Pinar Sefer, et al.
Lancet (London, England)|November 6, 2012
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 studyMarina Cuchel, Emma A Meagher, Hendrik du Toit Theron, et al.
The Australian and New Zealand Journal of Surgery|August 12, 1999
Practice parameters for the management of colonic cancer II: other issues. Recommendations of the Colorectal Surgical Society of AustraliaW Adams, J Cartmill, P Chapuis, et al.
The Australian and New Zealand Journal of Surgery|July 7, 1999
Practice parameters for the management of colonic cancer I: surgical issues. Recommendations of the Colorectal Surgical Society of AustraliaJ Moore, P Hewett, J C Penfold, et al.
Atherosclerosis|April 22, 2015
The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trialC Stefanutti, D J Blom, M R Averna, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|September 8, 2021
Mentoring Underrepresented Minority Physician-Scientists to SuccessAdina Kalet, Anne M Libby, Reshma Jagsi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2019
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding propertiesLynn E Macdonald, Karoline A Meagher, Matthew C Franklin, et al.
Lancet (London, England)|April 24, 2026
Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trialTuan Vu, Ali A Habib, Saiju Jacob, et al.
Science Immunology|December 17, 2021
Humanization of T cell-mediated immunity in miceMichael J Moore, Maggie Zhong, Johanna Hansen, et al.
Pageof 8